Literature DB >> 26868919

Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms.

Abby L Dotson1,2, Jianming Wang3, Jian Liang3, Ha Nguyen1,2, Dustin Manning1,2, Julie A Saugstad3, Halina Offner4,5,6.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARα) is a nuclear receptor transcription factor that plays a role in immune regulation. Because of its expression in cerebral tissue and immune cells, PPARα has been examined as an important regulator in immune-based neurological diseases. Many studies have indicated that pre-treatment of animals with PPARα agonists induces protection against stroke. However, our previous reports indicate that protection is only in males, not females, and can be attributed to different PPARα expression between the sexes. In the current study, we examine how loss of PPARα affects male and female mice in experimental stroke. Male and female PPARα knockout mice were subject to middle cerebral artery occlusion (MCAO) or sham surgery, and the ischemic (local) or spleen specific (peripheral) immune response was examined 96 h after reperfusion. We found that loss of PPARα perpetuated sex differences in stroke, and this was driven by the peripheral, not local, immune response. Specifically we observed an increase in peripheral pro-inflammatory and adhesion molecule gene expression in PPARα KO males after MCAO compared to females. Our data supports previous evidence that PPARα plays an important role in sex differences in the immune response to disease, including stroke.

Entities:  

Keywords:  Experimental stroke; Inflammation; Knock out; PPARα; Sex difference

Mesh:

Substances:

Year:  2016        PMID: 26868919      PMCID: PMC4864099          DOI: 10.1007/s11011-016-9805-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  34 in total

1.  Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.

Authors:  Dallas C Jones; Xiaohong Ding; Raymond A Daynes
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

2.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

3.  Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-α in the fed but not in the fasted state.

Authors:  Nicole Wege; Alexandra Schutkowski; Markus Boenn; Joanna Bialek; Axel Schlitt; Frank Noack; Ivo Grosse; Gabriele I Stangl
Journal:  FASEB J       Date:  2015-03-30       Impact factor: 5.191

4.  Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke.

Authors:  Abby L Dotson; Jianming Wang; Julie Saugstad; Stephanie J Murphy; Halina Offner
Journal:  J Neuroimmunol       Date:  2014-11-26       Impact factor: 3.478

5.  Effects of combination lipid therapy in type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.

Authors:  Hilary A Seifert; Christopher C Leonardo; Aaron A Hall; Derrick D Rowe; Lisa A Collier; Stanley A Benkovic; Alison E Willing; Keith R Pennypacker
Journal:  Metab Brain Dis       Date:  2012-02-22       Impact factor: 3.584

7.  Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice.

Authors:  Anirban Banerjee; Jianming Wang; Sheetal Bodhankar; Arthur A Vandenbark; Stephanie J Murphy; Halina Offner
Journal:  Transl Stroke Res       Date:  2013-10       Impact factor: 6.829

8.  The role of PPAR activation during the systemic response to brain injury.

Authors:  Patrick Losey; Emma Ladds; Maud Laprais; Borna Guevel; Laura Burns; Regis Bordet; Daniel C Anthony
Journal:  J Neuroinflammation       Date:  2015-05-22       Impact factor: 8.322

9.  Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate.

Authors:  J Trottier; P Caron; R J Straka; O Barbier
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

10.  Sex differences and the role of PPAR alpha in experimental stroke.

Authors:  Abby L Dotson; Jianming Wang; Yingxin Chen; Dustin Manning; Ha Nguyen; Julie A Saugstad; Halina Offner
Journal:  Metab Brain Dis       Date:  2015-11-18       Impact factor: 3.584

View more
  2 in total

Review 1.  Sex differences in the immune response to experimental stroke: Implications for translational research.

Authors:  Abby L Dotson; Halina Offner
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 2.  Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.

Authors:  Francisco Sáez-Orellana; Jean-Noël Octave; Nathalie Pierrot
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.